Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ribera

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Current HIV Research|June 22, 2012
Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 yearsD Podzamczer, J M Tiraboschi, J Mallolas, et al.
The Journal of Antimicrobial Chemotherapy|August 5, 2019
Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)M J Pérez Elías, B Alejos, M J Vivancos, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2019
Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)M J Pérez Elías, B Alejos, M J Vivancos, et al.
HIV Medicine|August 2, 2016
Very low level viraemia and risk of virological failure in treated HIV-1-infected patientsR Teira, F Vidal, P Muñoz-Sánchez, et al.
Open Forum Infectious Diseases|March 3, 2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)D Podzamczer, R Micán, J Tiraboschi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Current HIV Research|June 22, 2012
Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 yearsD Podzamczer, J M Tiraboschi, J Mallolas, et al.
The Journal of Antimicrobial Chemotherapy|August 5, 2019
Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)M J Pérez Elías, B Alejos, M J Vivancos, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2019
Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)M J Pérez Elías, B Alejos, M J Vivancos, et al.
HIV Medicine|August 2, 2016
Very low level viraemia and risk of virological failure in treated HIV-1-infected patientsR Teira, F Vidal, P Muñoz-Sánchez, et al.
Open Forum Infectious Diseases|March 3, 2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)D Podzamczer, R Micán, J Tiraboschi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 14